Texture analysis in contrast enhanced CT: New method to predict prognosis of small cell lung cancer treated with platinum-based chemotherapy

被引：0
|
作者：
Wang, M. [1 ]
Ma, X. [1 ]
机构：
[1] Sichuan Univ, State Key Lab Biotherapy, West China Hosp, Chengdu, Sichuan, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
26P
引用
收藏
页码：10 / 10
页数：1
相关论文
共 50 条
  • [31] Bevacizumab Plus Platinum-Based Chemotherapy In Advanced Non-Small Cell Lung Cancer
    Wagstaff, Antona J.
    Keam, Susan J.
    McCormack, Paul L.
    BIODRUGS, 2009, 23 (03) : 187 - 196
  • [32] Curative efficacy might be an early predictor of prognosis in patients with small cell lung cancer treated with 2 cycles of platinum-based first-line chemotherapy
    Zhu, Kaibo
    Jiang, Minlin
    Xu, Yi
    Chen, Peixin
    Wang, Hao
    Yu, Jia
    Zhu, Jun
    Zhao, Wencheng
    Meng, Die
    He, Yayi
    JOURNAL OF THORACIC DISEASE, 2021, 13 (02) : 1205 - 1214
  • [33] Predicting toxicity in advanced lung cancer patients treated with platinum-based chemotherapy
    Ioannidis, Georgios
    Souglakos, John
    Georgoulias, Vassilis
    LUNG CANCER MANAGEMENT, 2013, 2 (04) : 281 - 293
  • [34] Pretreatment serum syndecan-1 levels and outcome in small cell lung cancer patients treated with platinum-based chemotherapy
    Anttonen, A
    Leppä, S
    Ruotsalainen, T
    Alfthan, H
    Mattson, K
    Joensuu, H
    LUNG CANCER, 2003, 41 (02) : 171 - 177
  • [35] Pharmacogenetics of the DNA repair pathways in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy
    Sullivan, Ivana
    Salazar, Juliana
    Majem, Margarita
    Pallares, Cinta
    del Rio, Elisabeth
    Paez, David
    Baiget, Montserrat
    Barnadas, Agusti
    CANCER LETTERS, 2014, 353 (02) : 160 - 166
  • [36] Phase I study of amrubicin and vinorelbine in non-small cell lung cancer previously treated with platinum-based chemotherapy
    Oizumi, Satoshi
    Yamazaki, Koichi
    Yokouchi, Hiroshi
    Konishi, Jun
    Hommura, Fumihiro
    Kojima, Tetsuya
    Isobe, Hiroshi
    Nishimura, Masaharu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2009, 14 (02) : 125 - 129
  • [37] Haplotypes of BRCA1 and survival of non-small cell lung cancer patients treated with platinum-based chemotherapy
    Ryu, J.
    Shin, E.
    Lee, J.
    Yoo, Y.
    Cho, J.
    Kim, H.
    Lee, E.
    Kim, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [38] Clinical impact of pretreatment prognostic nutritional index (PNI) in small cell lung cancer patients treated with platinum-based chemotherapy
    Jin, Shi
    Cao, Shoubo
    Xu, Shanqi
    Wang, Chunyan
    Meng, Qingwei
    Yu, Yan
    CLINICAL RESPIRATORY JOURNAL, 2018, 12 (09): : 2433 - 2440
  • [39] Phase I study of amrubicin and vinorelbine in non-small cell lung cancer previously treated with platinum-based chemotherapy
    Satoshi Oizumi
    Koichi Yamazaki
    Hiroshi Yokouchi
    Jun Konishi
    Fumihiro Hommura
    Tetsuya Kojima
    Hiroshi Isobe
    Masaharu Nishimura
    International Journal of Clinical Oncology, 2009, 14 : 125 - 129
  • [40] INTRINSIC AND ACQUIRED RESISTANCE PATTERNS IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS TREATED WITH PLATINUM-BASED CHEMOTHERAPY
    Stewart, David J.
    Saintigny, Pierre
    Lu, Charles
    Goss, Glenwood
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S862 - S863
12345